Gram-Negative Bloodstream Infections
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (15 April 2020) | Viewed by 42588
Special Issue Editor
Interests: antimicrobial stewardship; antimicrobial resistance; bloodstream infections; sepsis; Gram-negative bacteria; antibiotics; antibacterial agents; urinary tract infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This special issue aims to highlight the recent advancements in the pathogenesis, epidemiology, diagnosis, and antimicrobial management of Gram-negative bloodstream infections. The morbidity and mortality of Gram-negative bloodstream infections have heavy burden on the general public and special populations such as immune compromised hosts. Changing epidemiology of antimicrobial resistance among Gram-negative bloodstream isolates emphasizes the dynamic interactions between hospitals and the community. Increasing antimicrobial resistance rates limit both empirical and definitive antimicrobial treatment options. Utilization of novel antimicrobial agents and cutting-edge treatment strategies through experimental and clinical therapeutics may improve clinical outcomes and advance this filed. Evolution of rapid diagnostics for early identification of bloodstream isolates as well as genotypic and phenotypic antimicrobial susceptibility testing provide opportunities for clinicians and researchers and hope for patients in a better future.
Prof. Majdi N. Al-Hasan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bloodstream infections
- bacteremia
- sepsis
- antibiotic resistance
- Gram-negative bacteria
- Enterobacteriaceae
- Escherichia coli
- Pseudomonas aeruginosa
- antimicrobial therapy
- rapid diagnostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.